DAFLON Film-coated tablet Ref.[50939] Active ingredients: Diosmin Hesperidin

Source: Marketing Authorisation Holder  Revision Year: 2019  Publisher: Les Laboratoires Servier France.

4.1. Therapeutic indications

  • Treatment of symptoms related to venolymphatic insufficiency (heavy legs, pain, early morning restless legs),
  • Treatment of functional symptoms related to acute hemorrhoidal attack.

4.2. Posology and method of administration

Usual dosage: 2 tablets daily in two divided doses, midday and evening at meal times.

Acute hemorrhoidal attack: 6 tablets per day for the first 4 days, then 4 tablets per day for 3 days.

4.9. Overdose

Symptoms

There is limited experience with Daflon overdose. The most frequently reported adverse events in overdose cases were gastrointestinal events (such as diarrhoea, nausea, abdominal pain) and skin events (such as pruritus, rash).

Management

Management of overdose should consist in treatment of clinical symptoms.

6.3. Shelf life

4 years.

6.4. Special precautions for storage

Below 30°C.

6.5. Nature and contents of container

15 or 30 tablets in blister packs (PVC-Aluminium).

Not all pack sizes may be marketed.

6.6. Special precautions for disposal and other handling

No special requirements.

< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈